# Characterization of the Prosocial and Prosexual Effects of GHB

> **NCT02342366** · NA · COMPLETED · sponsor: **University of Zurich** · enrollment: 19 (actual)

## Conditions studied

- Depressive Disorder, Major
- Bipolar Disorder
- Autistic Disorder

## Interventions

- **DRUG:** GHB 35 mg/kg p.o.
- **DRUG:** GHB 20 mg/kg p.o.

## Key facts

- **NCT ID:** NCT02342366
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2014-11
- **Final completion:** 2014-12
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2019-07-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02342366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02342366, "Characterization of the Prosocial and Prosexual Effects of GHB". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02342366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*